InSightec Ltd., the global leader in MR guided focused ultrasound technology announced today 31th of August 2010 that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
The ExAblate prostate system has been designed to provide effective treatments while minimizing the debilitating side-effects caused by damage to functional areas of the prostate and neurovascular bundles, thus the system is expected to enable patients to return to normal life within a day or two while maintaining their quality of life. The most common are incontinence and impotence
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...